Impact of preoperative [ 18 F]FDG PET/CT vs. contrast-enhanced CT in the staging and survival of patients with clinical stage I and II non-small cell lung cancer: a 10-year follow-up study.
Jun-Tao LinXiang-Meng LiWen-Zhao ZhongQing-Yi HouChun-Ling LiuXin-Yue YuKai-Yan YeYi-Lu ChengJia-Yu DuYun-Qing SunFu-Gui ZhangHong-Hong YanRi-Qiang LiaoSong DongBen-Yuan JiangSi-Yang LiuYi-Long WuXue-Ning YangPublished in: Annals of nuclear medicine (2023)
F]FDG PET/CT was associated with superior DFS and OS in resectable cI-II NSCLC, which may result from accurate staging and stage-appropriate therapy.
Keyphrases
- contrast enhanced
- diffusion weighted
- magnetic resonance imaging
- computed tomography
- lymph node
- magnetic resonance
- pet ct
- diffusion weighted imaging
- small cell lung cancer
- dual energy
- patients undergoing
- advanced non small cell lung cancer
- high resolution
- liver metastases
- locally advanced
- positron emission tomography
- mass spectrometry
- mesenchymal stem cells
- image quality
- tyrosine kinase